bioAffinity Techn…
USUSDbioAffinity Technologies, Inc. (US:BIAF) — Biotechnology: Commercial Physical & Biological Resarch. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 1. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site Web
- bioaffinitytech.com
- Relations avec les Investisseurs
- bioaffinitytech.com/contact/
- Secteur
- Health Care · Biotechnology: Commercial Physical & Biological Resarch
- Siège Social
- SAN ANTONIO, United States
- Direction
- Derniers Rapports
- Employés
- 57
- Actions en Circulation
- 8.1 M au 2026-08-03
- Flottant
- 532 257
- Capitalisation Boursière
- 3.69 M USD
- Initiés
- 0.82%
- Investisseurs Institutionnels
- 5.62%
- Secteur d'Activité (SIC)
- Services-Commercial Physical & Biological Research
- P/E
- perte
- P/B
- 5.04
- FCF
- −11.6 M USD
- Dette
- 36.5 k USDtrésorerie nette
- Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
- NAV
Description
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Bourses et Tickers
| Bourse | Ticker | Devise | Prix | Type |
|---|---|---|---|---|
| US USA Stocks | BIAF | USD | 2.83 +1.07% | actions ordinaires |
Principaux Actionnaires
| Détenteur | Participation | Actions | Date du Rapport |
|---|---|---|---|
| ZANNES MARIA (Chief Exec… | ≈46.94% | 280 359 | 2025-01-10 |
| EDWARDS JAMES MICHAEL CP… | ≈20.11% | 120 128 | 2025-01-10 |
| ZANNES TIMOTHY PETER (Ge… | ≈9.17% | 54 765 | 2025-01-10 |
| REVELES XAVIER TRINIDAD… | ≈7.02% | 41 943 | 2025-01-10 |
| Sabby Management, LLC | 4.06% | 24 377 | 2026-06-30 |
| Blackrock Inc. | 1.1% | 6 585 | 2026-06-30 |
| Vanguard Capital Managem… | 0.62% | 3 703 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.62% | 3 703 | 2026-06-30 |
| Geode Capital Management… | 0.57% | 3 398 | 2026-06-30 |
| J. Safra Sarasin Holding… | 0.47% | 2 840 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.34% | 2 071 | 2026-06-30 |
| Susquehanna Internationa… | 0.3% | 1 791 | 2026-06-30 |
| Jane Street Group, LLC | 0.3% | 1 786 | 2026-06-30 |
| Fidelity Concord Street… | 0.28% | 1 659 | 2026-07-31 |
| State Street Corporation | 0.27% | 1 606 | 2026-06-30 |
| HRT Financial LP | 0.23% | 1 389 | 2026-06-30 |
| Fidelity Concord Street… | 0.08% | 509 | 2026-07-31 |
| Fidelity Concord Street… | 0.07% | 434 | 2026-07-31 |
| Fidelity Concord Street… | 0.03% | 167 | 2026-07-31 |
| GIRGENTI STEVEN (Officer… | — | 1.09 M | 2025-01-10 |
